Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 3 5Phase 1 4Phase 1/2 3Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 2Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasms, Second Primary 1NSCLC 1Locally Advanced Breast Cancer 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

nedaplatin 1Fluorouracil 1Fibrin Tissue Adhesive 1Docetaxel 1Cisplatin 1Carboplatin 1Albumin-Bound Paclitaxel 1Acitretin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Squamous Cell × Docetaxel × Clear all
NCT02088515 2017-03-03

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 4 Completed
290 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡